<DOC>
	<DOC>NCT00132769</DOC>
	<brief_summary>This study will look at whether this new drug is effective in the treatment of rheumatoid arthritis, and at whether it is safe and well-tolerated by participants with the disease.</brief_summary>
	<brief_title>A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>MK 0873</mesh_term>
	<criteria>Rheumatoid arthritis, according to the American College of Rheumatology criteria, with active disease despite current medications Other criteria also apply Other major illnesses Past history of certain other disorders Certain prohibited medications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>